Objective: The aim of this study was to assess the ability of the modified contrast-enhanced ultrasound (CEUS) Liver Imaging Reporting and Data System (LI-RADS) to distinguish malignancy in patients without known hepatocellular carcinoma (HCC) risk factors and compare diagnostic accuracy with that of the World Federation for Ultrasound in Medicine and Biology (WFUMB) guideline across radiologists with different levels of CEUS experience.
Methods: A total of 848 individuals with no hepatitis infection presenting with 870 lesions in non-cirrhotic livers were included and divided into the Testing and Validation groups. The modified CEUS LI-RADS was proposed, including downgrading of focal nodular hyperplasia with typical features. Diagnostic performance of the modified CEUS LI-RADS was assessed in the Testing group. In the Validation group, two radiologists with more than 9 y of CEUS experience (Experts) and two radiologists with less than 6 mo of CEUS experience (Novices) used both the modified CEUS LI-RADS and the WFUMB guideline to evaluate performance in diagnosis of the lesions.
Results: LR-5 + M (combination of modified LR-5 and modified LR-M) revealed optimal performance with a sensitivity, specificity and area under the curve (AUC) of 99.3%, 81.6% and 0.904, respectively. Novices using the modified CEUS LI-RADS outperformed those using the WFUMB guideline (AUC: 0.858 vs. 0.767, p = 0.005). Additionally, the sensitivity, specificity and AUC of Novices were comparable to those of Experts using the modified CEUS LI-RADS (94.1%, 77.6% and 0.858 vs. 96.1%, 77.6% and 0.868 for experts, respectively).
Conclusion: The modified CEUS LI-RADS is a valuable method for distinguishing hepatic malignancy in patients without HCC risk factors. This is particularly beneficial for radiologists with limited CEUS expertise.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.ultrasmedbio.2023.10.008 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Potential for contrast-enhanced intraoperative ultrasonography with the Kupffer phase to improve and guide therapeutic strategies for hepatocellular carcinoma.
Quant Imaging Med Surg
December 2024
Department of General Surgery, Beijing Hospital, National Centre of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, China.
Article Synopsis
- CE-IOUS is a promising technique for improving detection of hidden HCC tumors during surgery, particularly for patients with cirrhosis, where traditional imaging may miss some lesions.
- A study involving 25 patients showed that CE-IOUS has a high sensitivity for detecting HCC lesions (96.5%), comparable to MRI and CEUS, suggesting its effectiveness in surgical settings.
- The findings indicate that utilizing CE-IOUS could enhance surgical strategies for HCC by identifying additional lesions that need to be addressed, potentially leading to better patient outcomes.
TME-Responsive Nanoplatform with Glutathione Depletion for Enhanced Tumor-Specific Mild Photothermal/Gene/Ferroptosis Synergistic Therapy.
Int J Nanomedicine
September 2024
Department of Ultrasound, Harbin Medical University Cancer Hospital, Harbin, 150081, People's Republic of China.
Article Synopsis
- Triple negative breast cancer (TNBC) is a challenging type of breast cancer that requires innovative treatment approaches due to its poor prognosis.
- Researchers developed a nanoplatform called PTFTH that utilizes gene therapy, photothermal therapy, and ferroptosis combined into one solution, targeting cancer cells specifically.
- In laboratory tests, PTFTH demonstrated effective tumor treatments by increasing oxidative stress in cancer cells and showed promise for imaging techniques like ultrasound and MRI, presenting a multi-faceted approach to combatting TNBC.
Combination of conventional ultrasound with quantitative and qualitative analyses of CEUS for the differentiation of benign and malignant breast solid lesions: A modified breast cancer model.
Asian J Surg
August 2024
Department of Ultrasound, Handan Central Hospital, Handan, China.
Objective: Breast cancer has become one of the main diseases threatening women's health and lives. Ultrasound (US) is the first diagnostic option for several patients because of its non-radiation, convenient, and low-cost features. Conventional US combined with contrast-enhanced US (CEUS) has improved diagnostic accuracy, while due to the presence of numerous parameters, no international consensus on diagnostic criteria could be attained.
View Article and Find Full Text PDFCEUS LI-RADS in Combination With the Serum Biomarker-Based ASAP Model Improves the Diagnostic Performance of HCC in High-Risk Patients.
Ultrasound Med Biol
November 2024
Department of Medical Ultrasound, The First Affiliated Hospital of Guangxi Medical University, Nanning, China. Electronic address:
Article Synopsis
- The study aimed to evaluate how effective the CEUS LI-RADS system is for diagnosing hepatocellular carcinoma (HCC) in high-risk patients when combined with the ASAP model based on age, sex, AFP, and PIVKA-II levels.
- Researchers analyzed 366 liver lesions and applied specific criteria to enhance the classification of uncertain lesions to a definitive diagnosis of HCC.
- The results showed that using the ASAP model significantly increased diagnostic sensitivity of LR-5 to 86.9%, while maintaining high specificity and positive predictive value, suggesting this approach benefits HCC diagnosis.
Evaluation of axillary lymph nodes in breast cancer patients with clinically negative axilla using contrast enhanced ultrasonography.
World J Surg Oncol
August 2024
Dept of Ophthalmology, Aligarh Muslim University, Aligarh, 202002, India.
Contrast enhanced ultrasonography enables dynamic evaluation of the microvasculature down to the capillaries when using high resolution ultrasound probes. It's application in the evaluation of axillary lymph nodes in breast cancer patients with clinically negative axilla has been studied in 42 patients. The results of pre operative CEUS evaluation was correlated with histopathology status of axillary nodes after the harvesting of nodes during modified radical mastectomy or sentinel node biopsy.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!